195 related articles for article (PubMed ID: 38338867)
21. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
Çelik H; Sciandra M; Flashner B; Gelmez E; Kayraklıoğlu N; Allegakoen DV; Petro JR; Conn EJ; Hour S; Han J; Oktay L; Tiwari PB; Hayran M; Harris BT; Manara MC; Toretsky JA; Scotlandi K; Üren A
Oncogene; 2018 Apr; 37(16):2181-2196. PubMed ID: 29382926
[TBL] [Abstract][Full Text] [Related]
22. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
23. Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma.
Steinestel K; Trautmann M; Jansen EP; Dirksen U; Rehkämper J; Mikesch JH; Gerke JS; Orth MF; Sannino G; Arteaga MF; Rossig C; Wardelmann E; Grünewald TGP; Hartmann W
Mol Oncol; 2020 Feb; 14(2):248-260. PubMed ID: 31811703
[TBL] [Abstract][Full Text] [Related]
24. EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.
Tanner JM; Bensard C; Wei P; Krah NM; Schell JC; Gardiner J; Schiffman J; Lessnick SL; Rutter J
Mol Cancer Res; 2017 Nov; 15(11):1517-1530. PubMed ID: 28720588
[TBL] [Abstract][Full Text] [Related]
25. Development of an Ewing sarcoma cell line with resistance to EWS‑FLI1 inhibitor YK‑4‑279.
Conn E; Hour S; Allegakoen D; Graham G; Petro J; Kouassi-Brou M; Hong SH; Selvanathan S; Çelik H; Toretsky J; Üren A
Mol Med Rep; 2020 Mar; 21(3):1667-1675. PubMed ID: 32016454
[TBL] [Abstract][Full Text] [Related]
26. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
28. Correlation NKX2.2 IHC and
Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
[TBL] [Abstract][Full Text] [Related]
29. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
30. Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.
Zhang P; Samuel G; Crow J; Godwin AK; Zeng Y
Transl Res; 2018 Nov; 201():136-153. PubMed ID: 30031766
[TBL] [Abstract][Full Text] [Related]
31. miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness.
De Feo A; Pazzaglia L; Ciuffarin L; Mangiagli F; Pasello M; Simonetti E; Pellegrini E; Ferrari C; Bianchi G; Spazzoli B; Scotlandi K
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406534
[TBL] [Abstract][Full Text] [Related]
32. Ewing sarcoma family of tumors.
Khoury JD
Adv Anat Pathol; 2005 Jul; 12(4):212-20. PubMed ID: 16096383
[TBL] [Abstract][Full Text] [Related]
33. FOXM1 is an oncogenic mediator in Ewing Sarcoma.
Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA
PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673
[TBL] [Abstract][Full Text] [Related]
34. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
McKinsey EL; Parrish JK; Irwin AE; Niemeyer BF; Kern HB; Birks DK; Jedlicka P
Oncogene; 2011 Dec; 30(49):4910-20. PubMed ID: 21643012
[TBL] [Abstract][Full Text] [Related]
35. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
36. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
37. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
Sankar S; Bell R; Stephens B; Zhuo R; Sharma S; Bearss DJ; Lessnick SL
Oncogene; 2013 Oct; 32(42):5089-100. PubMed ID: 23178492
[TBL] [Abstract][Full Text] [Related]
38. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
[TBL] [Abstract][Full Text] [Related]
39. Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.
Elzi DJ; Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2014 Aug; 13(8):3783-91. PubMed ID: 24999758
[TBL] [Abstract][Full Text] [Related]
40. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]